MKM Partners Maintains Buy on Cincinnati Financial, Raises Price Target to $160
MKM Partners analyst Harry Fong maintains Cincinnati Financial (NASDAQ:CINF) with a Buy and raises the price target from $150 to $160.
This Is How To Make $1000/mo In Passive Income With These Top 9 Dividend Stocks To Hold Forever
Do you want to make $1000 a month in passive income? I don't blame you; I mean, who wouldn't want to earn that. This article will cover investing in dividend stocks to get you to $1000 a month in passive income. What would you do with the money? Would you go on a vacation, say the Caribbean or on a cruise, or use it for a downpayment on a new home or a fancy new sports car?
Insurance Stocks Moving In Wednesday’s Intraday Session
According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.
3 Proven Stocks Setting Up For The Perfect Entry
Establishing high-probability assets is the essence of sound investing.
We do this through a proven analysis process and, ideally, one that is simple to follow and execute around your busy lifestyle.
Cincinnati Financial: Q4 Earnings Insights
Cincinnati Financial (NASDAQ:CINF) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Cincinnati Financial’s Earnings: A Preview
Cincinnati Financial (NASDAQ:CINF) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement.
Analysts estimate that Cincinnati Financial will report an earnings per share (EPS) of $1.35.
Death Cross Looms Over Cincinnati Financial Investors
If history is any guide, there may be trouble ahead for shares of Cincinnati Financial (NASDAQ:CINF). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
This Foreboding Sign Looms Over Cincinnati Financial’s Chart
If history is any guide, there may be trouble ahead for shares of Cincinnati Financial (NASDAQ:CINF). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
10 Biggest Price Target Changes For Thursday
SVB Leerink boosted the price target on Edwards Lifesciences Corporation (NYSE: EW) from $130 to $135. Edwards Lifesciences shares rose 1% to trade at $120.68 on Thursday.
Benzinga’s Top Ratings Upgrades, Downgrades For December 9, 2021
Upgrades
According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:NVEI) was changed from Market Perform to Outperform.